Pablo Francisco Belaunzarán-Zamudio, Livio Azzoni, David H. Canaday, Yanink N. Caro-Vega, Brian Clagget, Mohammed S Rassool, . . . Michael M. Lederman. (2017). Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial. Case Western Reserve University.
Chicago Style (17th ed.) CitationPablo Francisco Belaunzarán-Zamudio, et al. Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial. Case Western Reserve University, 2017.
MLA (9th ed.) CitationPablo Francisco Belaunzarán-Zamudio, et al. Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial. Case Western Reserve University, 2017.